SULFONYLIMIDE SALT AND METHOD FOR PRODUCING THE SAME
    2.
    发明申请
    SULFONYLIMIDE SALT AND METHOD FOR PRODUCING THE SAME 审中-公开
    磺酰亚胺盐及其制备方法

    公开(公告)号:WO2009123328A1

    公开(公告)日:2009-10-08

    申请号:PCT/JP2009/057010

    申请日:2009-03-30

    CPC classification number: C07C311/48 C07C303/40

    Abstract: The present invention provids a method for producing fluorosulfonylimides more safely, rapidly and efficiently, which enables suppression of production of by-products, and fluorosulfonylimides. The method for producing a fluorosulfonylimide salt of the present invention includes a step of reacting a fluoride compound containing at least one element selected from the group consisting of elements of Group 11 to Group 15 and Period 4 to Period 6 (excluding arsenic and antimony) with a compound represented by the following general formula (I) to give a fluorosulfonylimide salt represented by the general formula (II): [Chemical Formula 1] wherein R 1 denotes at least one element selected from the group consisting of elements of Group 11 to Group 15 and Period 4 to Period 6 (excluding arsenic and antimony); R 3 denotes fluorine, chlorine or a fluorinated alkyl group having 1 to 6 carbon atoms; R 4 denotes fluorine or a fluorinated alkyl group having 1 to 6 carbon atoms; and m denotes an integer of 2 or 3.

    Abstract translation: 本发明提供了更安全,快速,高效地制造氟磺酰亚胺的方法,能够抑制副产物和氟磺酰亚胺的生成。 本发明的含氟磺酰亚胺盐的制造方法包括使含有选自第11族元素​​〜第15族和第4期至第6期(砷和锑除外)中的至少一种元素的氟化合物与 由以下通式(I)表示的化合物,得到由通式(II)表示的氟磺酰亚胺盐:[化学式1]其中R1表示选自第11〜15族的元素中的至少一种元素 第4至第6期(不包括砷和锑); R3表示氟,氯或碳原子数1〜6的氟代烷基; R4表示氟或碳原子数1〜6的氟代烷基, m表示2或3的整数。

    RAPIDLY SOLIDIFIED FOIL FOR RING-LIKE WELDING MATERIAL, ITS PRODUCTION PROCESS AND APPARATUS, AND NOZZLE FOR PRODUCING THE SAME
    7.
    发明申请
    RAPIDLY SOLIDIFIED FOIL FOR RING-LIKE WELDING MATERIAL, ITS PRODUCTION PROCESS AND APPARATUS, AND NOZZLE FOR PRODUCING THE SAME 审中-公开
    用于环状焊接材料的快速固化箔及其制造方法和装置以及用于生产其的喷嘴

    公开(公告)号:WO1998000252A1

    公开(公告)日:1998-01-08

    申请号:PCT/JP1997002263

    申请日:1997-06-30

    CPC classification number: B23K35/0233 B22D11/0611

    Abstract: A rapidly solidified foil for a ring-like welding material is formed by spraying a molten metal on the side of a roll rotating at a high speed and rapidly solidifying the same, and the ring-like foil is formed into a coil. It has also a fold portion concentric with the rings. A nozzle opening surface is opposed to the roll side vertical or inclined to the axis of rotation, the opening is slit-like, the longitudinal direction of the opening is parallel to a radial direction of the roll side, the molten metal is sprayed, and the rapidly solidified foil is peeled. When pipes such as steel pipes are butt-welded with the pipe end surfaces vertical to the axis of the pipe, the rapidly solidified foil is placed between the pipe end surfaces. The rapidly solidified foil is produced with high yield and high working factor. Because the thickness in the width direction of the ring foil is made uniform or the surface area of the welding material is increased, the welding accuracy and welding strength are improved.

    Abstract translation: 用于环状焊接材料的快速凝固的箔通过在高速旋转的辊的侧面上喷射熔融金属并快速凝固而形成,并且环状箔形成为线圈。 它还具有与环同心的折叠部分。 喷嘴开口面与辊侧垂直或相对于旋转轴线倾斜,开口为狭缝状,开口的长度方向平行于辊侧的径向,喷出熔融金属, 快速凝固的箔被剥离。 当诸如钢管的管道与管端面垂直于管道的轴线对接时,快速凝固的箔片被放置在管端面之间。 以高产率和高工作系数生产快速凝固的箔。 由于使环状箔的宽度方向的厚度均匀,焊接材料的表面积增加,因此提高了焊接精度和焊接强度。

    SOLID FORMS OF SALTS WITH TYROSINE KINASE ACTIVITY
    9.
    发明申请
    SOLID FORMS OF SALTS WITH TYROSINE KINASE ACTIVITY 审中-公开
    具有酪氨酸激酶活性的固体形式

    公开(公告)号:WO2003088900A2

    公开(公告)日:2003-10-30

    申请号:PCT/US2003/011022

    申请日:2003-04-11

    IPC: A61K

    CPC classification number: C07D401/04

    Abstract: The present invention relates to solid forms of the hydrochloridesalt3-[5-(4-methanesulfonyl-piperazin-1-ylmethyl)-1H-indol-2-yl]-1H-quinolin-2-one which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angio-genesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.

    Abstract translation: 本发明涉及盐酸盐-3- [5-(4-甲磺酰基 - 哌嗪-1-基甲基)-1H-吲哚-2-基] -1H-喹啉-2-酮的固体形式,其抑制,调节和/或调节 酪氨酸激酶信号转导,含有这些化合物的组合物,及其用于治疗酪氨酸激酶依赖性疾病和病症如血管生成,癌症,肿瘤生长,动脉粥样硬化,年龄相关性黄斑变性,糖尿病性视网膜病变,炎性疾病, 和哺乳动物等。

Patent Agency Ranking